
Summary
The MAD has been an official Affymetrix GeneChips® service provider since 2002. The patented Affymetrix GeneChips® platform is the world's leading system in genome-wide expression analysis. More than one million different gene-specific oligonucleotides are synthesized in situ directly on the chip surface using a photolithographic procedure.
Strengths of the Affymetrix GeneChip® technology:
- minimal error due to closed system
- robost results due to the design of multiple probes per gene
- maximum control due to multiple quality controls
- high reproducibility due to highly standardized protocols
- fast data processing due to a direct link to comprehensive database
Applications of the Affymetrix GeneChip® technology:
Platforms Affymetrix GeneChip® technology: